These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Pathological changes associated with the inhalation of sodium zirconium lactate. PRIOR JT; CRONK GA; ZIEGLER DD Arch Environ Health; 1960 Oct; 1():297-300. PubMed ID: 13738075 [No Abstract] [Full Text] [Related]
6. Pathological changes associated with aluminum and zirconium compounds. (An experimental study of skin pathology following the application of aluminum chlorohydroxide, aluminum sulfate, sodium aluminum lactate, and zircontum tetraisopropoxide. PRIOR JT; CRONK GA Arch Dermatol; 1959 Oct; 80():447-54. PubMed ID: 14434953 [No Abstract] [Full Text] [Related]
7. The zirconium deodorant granuloma: an allergic disorder. HURLEY HJ; SHELLEY WB Henry Ford Hosp Med Bull; 1958 Sep; 6(3):279-90. PubMed ID: 13610279 [No Abstract] [Full Text] [Related]
8. Evaluating the effects of aluminum-containing and non-aluminum containing deodorants on axillary skin toxicity during radiation therapy for breast cancer: a 3-armed randomized controlled trial. Lewis L; Carson S; Bydder S; Athifa M; Williams AM; Bremner A Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):765-71. PubMed ID: 25194668 [TBL] [Abstract][Full Text] [Related]
9. Effective axillary malodour reduction by polyquaternium-16-containing deodorants. Traupe B; Fölster H; Max H; Schulz J Int J Cosmet Sci; 2017 Apr; 39(2):141-148. PubMed ID: 27506727 [TBL] [Abstract][Full Text] [Related]
10. [Deodorants and antiperspirants]. Martini MC Ann Dermatol Venereol; 2020 May; 147(5):387-395. PubMed ID: 32248967 [TBL] [Abstract][Full Text] [Related]
11. Use of deodorants during adjuvant breast radiotherapy: a survey of compliance with standard advice, impact on patients and a literature review on safety. Graham PH; Graham JL J Med Imaging Radiat Oncol; 2009 Dec; 53(6):569-73. PubMed ID: 20002290 [TBL] [Abstract][Full Text] [Related]